In this “Hot Topic,” Paul Jannetto, Ph.D., highlights Mayo Clinic Laboratories’ AI-augmented kidney stone test and discusses the proper procedures for collecting and processing kidney stones to provide accurate, cost-effective analysis of patients’ kidney stones in a timely manner.

By MCL Education • April 12, 2023

This month’s “Virtual Lecture” discusses the health implications of the use of race in estimating glomerular filtration rate (eGFR), how to estimate GFR, and why it is important to continue funding and research to develop tools without the use of race.

By MCL Education • July 27, 2022

A collaborative study between Mayo Clinic and the University of Illinois debunked the previous consensus about how kidney stones grow.

By Chris Bahnsen • June 1, 2021

Part II of this series shows how a breakthrough discovery about how kidney stones form may open the way for new, unorthodox treatments. The discovery was made possible by joining University of Illinois’ geology and biology forces with Mayo Clinic’s urology and nephrology expertise.

By Chris Bahnsen • June 1, 2021

Mayo Clinic researchers are tracking the familiar characteristics of kidney stone formers in an online prediction tool that could help sufferers anticipate if they'll experience future episodes.

By Mayo Clinic News Network • February 5, 2019

This week’s Research Roundup highlights the evaluation of monoclonal gammopathy of renal significance: A consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

By Kelley Luedke • December 10, 2018

This week’s Research Roundup highlights predicting renal function outcomes after partial and radical nephrectomy.

By Kelley Luedke • December 3, 2018

This week’s Research Roundup highlights the clinical and pathology findings associated consistently with larger glomerular volume.

By Kelley Luedke • May 28, 2018

The National Kidney Foundation, the American Society for Clinical Pathology, and the nation’s leading laboratories and clinical laboratory societies have announced a new collaboration to remove barriers to testing for chronic kidney disease.

By Gina Chiri-Osmond • February 27, 2018

This week’s Research Roundup highlights how the DnaJ heat shock protein family B member 9 is a novel biomarker for fibrillary GN.

By Kelley Luedke • November 13, 2017

A team of Mayo Clinic pathologists have discovered a new tissue biomarker, DNAJB9, for fibrillary glomerulonephritis, a rare kidney disease of unknown pathogenesis and poor outlook—nearly half of all patients end up on dialysis within four years of diagnosis.

By Chris Bahnsen • October 17, 2017

This week’s Research Roundup highlights noninvasive assessment of renal fibrosis with magnetization transfer MR imaging.

By Kelley Luedke • June 12, 2017